Dramatic Changes in Thiopurine Metabolite Levels in a Patient With Inflammatory Bowel Disease Treated With Tirzepatide for Weight Loss.
使用 Tirzepatide 減重的炎症性腸病患者硫嘌呤代謝物水平的劇變。
ACG Case Rep J 2024-11-07
Use and Interchange of Incretin Mimetics in the Treatment of Metabolic Diseases: A Narrative Review.
胰高血糖素類似物在治療代謝性疾病中的使用與互換:敘事性回顧。
Clin Ther 2023-05-10
Impact of tirzepatide in a patient with type 1 diabetes and obesity: A case report.
Tirzepatide對一名患有第1型糖尿病和肥胖症患者的影響:一個病例報告。
J Am Pharm Assoc (2003) 2024-04-18
Effect on Hemoglobin A1c (HbA1c) and Body Weight After Discontinuation of Tirzepatide, a Novel Glucose-Dependent Insulinotropic Peptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist: A Single-Center Case Series Study.
停用新型葡萄糖依賴性胰島素促分泌肽(GIP)和葡萄糖樣肽-1(GLP-1)受體激動劑 Tirzepatide 後對血紅蛋白A1c(HbA1c)和體重的影響:單一中心病例系列研究。
Cureus 2023-10-26
A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide.
對雙糖依賴性胰島素促泌肽/葡萄糖樣胰高血糖素-1受體激動劑 Tirzepatide 引起全身過敏反應之病例報告。
Cureus 2024-02-02
Safety and Efficacy of Switching Patients With Type 2 Diabetes From Glucagon-Like Peptide-1 Receptor Agonists to Tirzepatide: A Case Series.
將2型糖尿病患者從胰高血糖素樣肽-1受體激動劑轉換至Tirzepatide的安全性與療效:案例系列。
Hosp Pharm 2024-10-25
Effect of switching from dulaglutide to tirzepatide on blood glucose and renal function.
從 dulaglutide 轉換至 tirzepatide 對血糖和腎功能的影響。
Drug Discov Ther 2024-10-27